HIV and AIDS Trial, Recruiting NCT05509959 Sponsor: University of California, San Diego Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05509959
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who identify as cisgender female (born female and still identify as female)
  • People who have been diagnosed with HIV by a doctor, healthcare provider, or community health worker
  • People aged 18 years or older
  • People who can speak and read English or Spanish
  • People who have experienced interpersonal violence (such as abuse or assault) as an adult
  • People who are currently prescribed HIV treatment (antiretroviral therapy/ART)
  • People who report taking their HIV medication less than 90% of the time in the past month
  • People who are not currently taking part in another program focused on HIV medication adherence
  • People who have access to an internet browser

Who may not be able to join:

  • People who are unwilling to take part in the intervention
  • People who identify as transgender female
  • People who have not received an HIV diagnosis from a doctor, healthcare provider, or community health worker
  • People under 18 years of age
  • People who do not speak and read English or Spanish
  • People who are not currently prescribed HIV treatment
  • People who report taking their HIV medication 90% or more of the time in the past month
  • People currently taking part in another HIV medication adherence program
  • People without access to an internet browser
  • People whose cognitive (thinking or memory) difficulties would prevent them from giving informed consent to participate
  • People whose only experiences of interpersonal violence occurred during childhood, with no adult experiences
  • People identified through a secondary screening process as unable to safely participate in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jamila K Stockman, PhD, MPH, University of California, San Diego

Phone: (858) 534-7979

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 November 2022
Est. completion
1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in ART Adherence; Change in ART Adherence; Change in PTSD Symptoms; Change in Emotion Regulation; Change in Individual and Socio-Structural Mechanisms of Change; Change in Individual and Socio-Structural Mechanisms of Change; Change in Individual and Socio-Structural Mechanisms of Change; Change in Individual and Socio-Structural Mechanisms of Change; Change in Individual and Socio-Structural Mechanisms of Change; Change in Individual and Socio-Structural Mechanisms of Change

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov